Article Menu

Academic Editors

Pierluigi Toniutto

Hidekazu Suzuki
Subscribe SciFeed
Recommended Articles
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessReview

Article Versions Notes

J. Clin. Med. 2021, 10(15), 3201; https://doi.org/10.3390/jcm10153201

Action	Date	Notes	Link
article xml file uploaded	21 July 2021 11:02 CEST	Original file	-
article xml uploaded.	21 July 2021 11:02 CEST	Update	https://www.mdpi.com/2077-0383/10/15/3201/xml
article pdf uploaded.	21 July 2021 11:02 CEST	Version of Record	https://www.mdpi.com/2077-0383/10/15/3201/pdf
article html file updated	21 July 2021 11:03 CEST	Original file	-
article html file updated	27 July 2022 05:47 CEST	Update	https://www.mdpi.com/2077-0383/10/15/3201/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Plaz Torres, M.C.; Lai, Q.; Piscaglia, F.; Caturelli, E.; Cabibbo, G.; Biasini, E.; Pelizzaro, F.; Marra, F.; Trevisani, F.; Giannini, E.G. Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. J. Clin. Med. 2021, 10, 3201. https://doi.org/10.3390/jcm10153201

AMA Style

Plaz Torres MC, Lai Q, Piscaglia F, Caturelli E, Cabibbo G, Biasini E, Pelizzaro F, Marra F, Trevisani F, Giannini EG. Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. Journal of Clinical Medicine. 2021; 10(15):3201. https://doi.org/10.3390/jcm10153201

Chicago/Turabian Style

Plaz Torres, Maria Corina, Quirino Lai, Fabio Piscaglia, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, and Edoardo G. Giannini. 2021. "Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting" Journal of Clinical Medicine 10, no. 15: 3201. https://doi.org/10.3390/jcm10153201

APA Style

Plaz Torres, M. C., Lai, Q., Piscaglia, F., Caturelli, E., Cabibbo, G., Biasini, E., Pelizzaro, F., Marra, F., Trevisani, F., & Giannini, E. G. (2021). Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. Journal of Clinical Medicine, 10(15), 3201. https://doi.org/10.3390/jcm10153201

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI